BioNTech plant Mitte 2022 den Baubeginn einer mRNA Impfstoff-Produktionsstätte in Afrika
26 oct. 2021 08h00 HE
|
BioNTech SE
BioNTech unterzeichnet eine Absichtserklärung mit der ruandischen Regierung und dem Institut Pasteur de Dakar. Der Baubeginn für die erste mRNA-Produktionsstätte in Afrika ist für Mitte 2022...
BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022
26 oct. 2021 08h00 HE
|
BioNTech SE
BioNTech signs Memorandum of Understanding with Rwandan Government and the Institut Pasteur de Dakar. Construction of the first mRNA manufacturing facility in Africa is planned to be initiated in...
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
22 juin 2021 01h00 HE
|
Translate Bio, Inc.
-- Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise -- -- Positive preclinical safety and immunogenicity data...
Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
07 juin 2021 07h30 HE
|
Translate Bio, Inc.
-- $50 million milestone payment to be received this month for successful manufacturing, release, and delivery of clinical drug product to support influenza mRNA vaccine clinical trial anticipated to...
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
19 avr. 2021 07h30 HE
|
Translate Bio, Inc.
-- Multiple antigen constructs, including the construct used in MRT5500, induced potent neutralizing antibodies against SARS-CoV-2 in preclinical studies in multiple species -- -- Efficacy...
Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
12 mars 2021 01h00 HE
|
Translate Bio, Inc.
-- Clinical trial to assess safety, immune response and reactogenicity, after preclinical data showed high neutralizing antibody levels -- -- Expected to enroll 415 participants; interim results...
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
25 févr. 2021 16h05 HE
|
Translate Bio, Inc.
-- Additional interim data expected in early Q2 from Phase 1/2 clinical trial of MRT5005 for the treatment of cystic fibrosis (CF) -- -- Two infectious disease mRNA vaccine programs expected to enter...
Global mRNA Vaccine And Therapeutics Market 2021 Analysis By Advanced Technology, Size-Share, Industry Dynamic (Drivers, Trends, Challenges, Restraints), Market Contribution, Top Companies Strategy, and Consumption Trend till 2027
22 févr. 2021 04h24 HE
|
Industry Research
Pune, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Global mRNA Vaccine And Therapeutics Market 2021-2027: "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “mRNA...
Translate Bio to Participate in Upcoming Investor Conferences
12 nov. 2020 07h30 HE
|
Translate Bio, Inc.
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...